DNA testing developer Natera is suing ArcherDX, a molecular technology company, for allegedly infringing a patent related to multiplex polymerase chain reaction technology.
The US Federal Trade Commission and New York’s attorney general have sued incarcerated ‘pharma bro’ Martin Shkreli for allegedly monopolising the market for life-saving drug Daraprim.
Biopharmaceutical company AbbVie’s pending purchase of pharmaceutical company Allergan has moved a step closer, following the latter’s agreement to divest treatments brazikumab and Zenpep, in a development meant to satisfy antitrust regulations in the US.
Arnold & Porter partner Richard Dickinson has joined Bristows as a partner in its commercial and IP transactional practice in London.
Parker Poe Adams & Bernstein has announced the addition of five patent attorneys to its life sciences team.
Gilead Sciences has accused a US government agency of withholding information from the US Patent and Trademark Office when filing two patents for HIV pre-exposure prophylaxis.
Jason Markwell, a former partner at Belmore Neidrauer, has joined Fasken’s IP group in its Toronto office.
The Court of Justice of the European Union has rejected two appeals that would have restricted the European Medicines Agency’s right to publish a pharmaceutical company’s clinical trial data, as it relates to their applications to market their products within the EU.
Molecular testing company Ascenda BioSciences is suing a former chief operations officer, claiming he attempted to “extort” the return of sensitive company information before taking up employment with a direct competitor.
Washington State University is suing two apple producers who it says have infringed its patent through the unlicensed cultivation and sale of a proprietary apple variety.